New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

How Did COVID Vaccine Plants Get Built So Quickly?

Expedited vaccine development required special planning to ensure mass production capacity.

We all know the COVID-19 vaccine was developed in record time, but have you pondered how the manufacturing facilities were built to support mass production and distribution? A recent Fast Company article took a look inside these quick-build factories and shed some light on how they were built concurrently with vaccine development. Typically, this process would take years, but Lonza employed a new method that expedited the process to just months.

Because the vaccine was still in development, they couldn’t build a new factory specific to it. Instead, they created shells of buildings that could be modified quickly for various purposes. The shells were preemptively connected to central infrastructure to provide utilities pertinent to bioproduction such as sterile water, steam, and gas. With these shells, the builders were able to drop in the manufacturing technology required for the specific vaccine.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub